PointState Capital’s Chemed CHE Stock Holding History

PointState Capital’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,275	Closed	-$2.81M	–	131
2020 Q4	$2.81M	Buy	5,275 +3,000	+132%	+$1.47M	0.05%	105
2020 Q3	$1.09M	Buy	+2,275	New	+$1.12M	0.03%	94

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

PointState Capital's CHE Position: Q1 2021 in Review

PointState Capital sold out of Chemed (CHE) in Q1 2021, closing a stake of 5,275 shares — an estimated $2.81M sold.

PointState Capital first reported a position in CHE in Q3 2020 and held it in 2 quarters. The position peaked at $2.81M in Q4 2020. 421 funds tracked by Wall St. Rank hold CHE as of Q1 2021.

PointState Capital reported no remaining Chemed position as of Q1 2021 after selling out during the quarter.
PointState Capital sold 5,275 Chemed shares in Q1 2021, an estimated $2.81M.
PointState Capital first reported a position in Chemed in Q3 2020 and held it in 2 quarters.
PointState Capital's Chemed position peaked at $2.81M in Q4 2020.
421 funds tracked by Wall St. Rank held Chemed as of Q1 2021.

Based on PointState Capital's 13F filing for Q1 2021, filed 14 May 2021.